YHYongwen He

Yongwen He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yongwen He has a total of 132 co-authors. Here are the top co-authors by number of shared publications:

  • Li Bian

    The First Affiliated Hospital of Kunming Medical University, Kunming, China

    11 shared publications
  • Lei Li

    Department of Head and Neck Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650118, P.R. China

    4 shared publications
  • Li Bian

    Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Kunming, China

    4 shared publications
  • Dingyun You

    School of Public Health, Kunming Medical University

    3 shared publications
  • Jianhua Wu

    Department of Periodontology, The Affiliated Stomatological Hospital of Kunming Medical University, Kunming, Yunnan 530102, P.R. China

    3 shared publications
  • Jianqi Liu

    Department of Stomatology, The Affiliated Yan'an Hospital of Kunming Medical University, Kunming, Yunnan 650051, P.R. China

    3 shared publications

Latest Publications

  • Open Access

    FBXL18 ubiquitinates and degrades MDFI to suppress Wnt/β-catenin signaling and reverse cisplatin resistance in lung cancer

    by Yanghao Wang, Weizhou Wang, Guoyu Li, Hengrui Zhang, Jingying Wang, Daolang Yuan, Xiang Li, Xiuyu Liu, Guodong Lv, Yingying Zou, et al.

  • Open Access

    Spatial Location of SPP1 + TAMs and Mutually Exclusive Subsets Based on Single‐Cell and Transcriptome Data

    by Xuan Luo, JianGuo Xu, ZhiYuan Wang, XiaoFang Wang, YangHao Wang, Yu Zhang, FangFang Li, Hui Fang, XiaoYun Huang, MuYe Li, et al.

    To clarify locations and mutually exclusive subsets of SPP1 + tumor associated macrophages (SPP1 + TAMs) in lung adenocarcinoma (LUAD). Analyze the polarization type, mutually exclusive cell subset, and spatial location of SPP1 + TAMs based on the transcriptome data of the Cancer Genome Atlas (TCGA) and Genotype‐Tissue Expression (GTEx) database, single‐cell and spatial transcriptome data of the Gene Expression Omnibus database (GEO), immunohistochemical data of the Human Protein Atlas (HPA) database and local LUAD to provide a scientific basis for precision treatment of LUAD. Secreted phosphoprotein‐1 (SPP1) was identified as the central regulatory gene of LUAD. The single‐cell transcriptome data showed that SPP1 is up‐regulated in invasive lung carcinoma (ILC), while macrophage receptor with collagenous structure (MARCO) is up‐regulated in adenocarcinoma in situ (AIS). MARCO + M2 macrophages and SPP1 + M2 macrophages clustered in different positions in the uniform manifold approximation and projection (UMAP) to form mutually exclusive cell subsets. SPP1 + M2 plays a major role in ILC and MARCO + M2 plays a major role in AIS. The spatial transcriptome data showed that some SPP1 + M2 were clustered at the edge of the tumor, and this particular spatial location may increase tumor invasiveness. Further spatial distance analysis showed that the distance was greater from the SPP1 + M2 to alveolar type 2 epithelial cell (AT2) than from the MARCO + M2. Immunohistochemical analysis showed that SPP1 expression was up‐regulated in the tumor or ILC group and notably higher in inflammatory cells. In summary, SPP1 + M2 and MARCO + M2 form mutually exclusive cell subsets, and MARCO + M2 and SPP1 + M2 synergistically promote different stages of tumor progression.


  • DTL promotes head and neck squamous cell carcinoma progression by mediating the degradation of ARGLU1 to regulate the Notch signaling pathway

    by Jingpei Shi, Xiaonan Yu, Guoyu Li, Xiaoyu Zhao, Jiwen Chen, Ying Fang, Yan Yang, Ting Wang, Tianyong Xu, Li Bian, et al.


  • Top Cited Papers
    Open Access

    Mapping of individual sensory nerve axons from digits to spinal cord with the transparent embedding solvent system

    by Yating Yi, Youqi Li, Shiwen Zhang, Yi Men, Yuhong Wang, Dian Jing, Jiayi Ding, Qingjie Zhu, Zexi Chen, Xingjun Chen, et al.

    Achieving uniform optical resolution for a large tissue sample is a major challenge for deep imaging. For conventional tissue clearing methods, loss of resolution and quality in deep regions is inevitable due to limited transparency. Here we describe the Transparent Embedding Solvent System (TESOS) method, which combines tissue clearing, transparent embedding, sectioning and block-face imaging. We used TESOS to acquire volumetric images of uniform resolution for an adult mouse whole-body sample. The TESOS method is highly versatile and can be combined with different microscopy systems to achieve uniformly high resolution. With a light sheet microscope, we imaged the whole body of an adult mouse, including skin, at a uniform 0.8 × 0.8 × 3.5 μm3 voxel resolution within 120 h. With a confocal microscope and a 40×/1.3 numerical aperture objective, we achieved a uniform sub-micron resolution in the whole sample to reveal a complete projection of individual nerve axons within the central or peripheral nervous system. Furthermore, TESOS allowed the first mesoscale connectome mapping of individual sensory neuron axons spanning 5 cm from adult mouse digits to the spinal cord at a uniform sub-micron resolution.


  • Open Access

    PDGF-BB accelerates TSCC via fibroblast lactates limiting miR-26a-5p and boosting mitophagy

    by Jianguo Xu, Li Bian, Dingyun You, Ziliang Li, Tingting Wang, Yiting Li, Xiaobin Ren, Yongwen He

    The tumor microenvironment and cancer-associated fibroblasts (CAFs) play crucial roles in tumor development, and their metabolic coupling remains unclear. Clinical data showed a positive correlation between PDGF-BB, CAFs, and glycolysis in the tumor microenvironment of oral tongue squamous cell carcinoma patients. In vitro, CAFs are derived from hOMF cells treated with PDGF-BB, which induces their formation and promotes aerobic glycolysis. Mitophagy increased the PDGF-BB-induced formation of CAF phenotypes and aerobic glycolysis, while autophagy inhibition blocked PDGF-BB-induced effects. Downregulation of miR-26a-5p was observed in CAFs; upregulation of miR-26a-5p inhibited the expression of mitophagy-related proteins ULKI, Parkin, PINK1, and LC3 and aerobic glycolysis in PDGF-BB-induced CAFs. PDGF-BB-induced CAFs promoted tumor cell proliferation, invasion, metastasis, NF-κB signaling pathway activation, and PDGF-BB secretion. Thus, PDGF-BB is associated with lactate-induced CAF formation and glucose metabolism reprogramming. These findings indicate potential therapeutic targets in oral tongue squamous cell carcinoma.


  • Open Access

    MiR-3529-3p from PDGF-BB-induced cancer-associated fibroblast-derived exosomes promotes the malignancy of oral squamous cell carcinoma

    by Dingyun You, Yanghao Wang, Jianguo Xu, Rongqiang Yang, Weizhou Wang, Xiaofang Wang, Xue Cao, Yiting Li, Lifu Yu, Weihong Wang, et al.

    Aims: This study aims to explore the role of exosomes from cancer-associated fibroblasts (CAFs) induced by PDGF-BB in promoting the malignancy of oral squamous cell carcinoma (OSCC) and provide new insight into the mechanism of OSCC progression and its treatment. Main methods: Exosomes were extracted from human oral mucosa fibroblasts (hOMFs) and CAFs. Differentially expressed miRNAs of exosomes between hOMFs and CAFs were analysed using high-throughput sequencing and self-programmed R software. Cal-27, a human tongue squamous carcinoma cell line, was treated with exosomes. Differentially expressed miRNAs between clinical cancer tissues and adjacent tissues and between hOMF and CAF exosomes were verified by qRT‒PCR. The effect of miR-3529-3p on Cal-27 cells was clarified by overexpressing or knocking down miR-3529-3p in Cal-27 cells. Sample expression and differentially expressed miRNA expression were compared between cancer and paracarcinoma tissues. Key findings: We found that exosomes from CAFs (CAF-Exos) were internalized by tongue squamous carcinoma cells and promoted their proliferation, migration, invasion, and antiapoptotic effects. MiR-3529-3p was a significant differentially expressed miRNA between CAF-Exos and exosomes from hOMFs (hOMF-Exos). The overexpression of miR-3529-3p promoted proliferation, migration, and invasion and inhibited apoptosis of Cal-27 cells. Significance: This study explores the role of PDGF-BB-induced CAFs in promoting malignancy in OSCC. This study will provide new insight into the mechanism of OSCC progression and its treatment.


  • Open Access

    Analysis of mRNA-miRNA interaction network reveals the role of CAFs-derived exosomes in the immune regulation of oral squamous cell carcinoma

    by Wei-Zhou Wang, Xue Cao, Li Bian, Yue Gao, Ming Yu, Yi-Ting Li, Jian-Guo Xu, Yang-Hao Wang, He-Feng Yang, Ding-Yun You, et al.

    Background: Cancer-associated fibroblasts (CAFs) have significant tumor regulatory functions, and CAFs-derived exosomes (CAFs-Exo) released from CAFs play an important role in the progression of oral squamous cell carcinoma (OSCC). However, a lack of comprehensive molecular biological analysis leaves the regulatory mechanisms of CAFs-Exo in OSCC unclear. Methods: We used platelet derived growth factor-BB (PDGF-BB) to induce the transformation of human oral mucosa fibroblast (hOMF) into CAFs, and extracted exosomes from the supernatant of CAFs and hOMF. We validated the effect of CAFs-Exo on tumor progression by exosomes co-culture with Cal-27 and tumor-forming in nude mice. The cellular and exosomal transcriptomes were sequenced, and immune regulatory genes were screened and validated using mRNA-miRNA interaction network analysis in combination with publicly available databases. Results: The results showed that CAFs-Exo had a stronger ability to promote OSCC proliferation and was associated with immunosuppression. We discovered that the presence of immune-related genes in CAFs-Exo may regulate the expression of PIGR, CD81, UACA, and PTTG1IP in Cal-27 by analyzing CAFs-Exo sequencing data and publicly available TCGA data. This may account for the ability of CAFs-Exo to exert immunomodulation and promote OSCC proliferation. Conclusions: CAFs-Exo was found to be involved in tumor immune regulation through hsa-miR-139-5p, ACTR2 and EIF6, while PIGR, CD81, UACA and PTTG1IP may be potentially effective targets for the treatment of OSCC in the future.


  • Activated fibroblasts induce immune escape of TSCC through CCL25/AKT pathway

    by Yiting Li, Ken Lin, Xiaobin Ren, Jianguo Xu, Haiming Yuan, Li Bian, Yongwen He

    Objectives: Accumulating evidence suggests that activated fibroblasts are the key cells in the T-cell response to tumor immunosuppression. We attempted to investigate the effect of activated fibroblasts on PD-L1 expression and the related immune escape mechanism in tongue squamous cell carcinoma. Methods: Western blotting, qPCR, and other techniques were used to study the expression of PD-L1 in tongue squamous cell carcinoma cells and the nude mouse model of transplanted tumors in vivo; clinical tissue samples were verified. In addition, we established a direct coculture model of T cells and tongue squamous cell carcinoma cells explore the mechanisms of immune escape. Results: We found that PDGF-BB induces fibroblast activation by facilitating the oversecretion of chemokine CCL25. Further analysis showed that CCL25 derived from activated fibroblasts activated the Akt signaling pathway to promote PD-L1 expression. The activated fibroblasts inhibited T-cell IFN-gamma secretion through the CCL25/Akt/PD-L1 pathway. which indirectly inhibited T-cell proliferation. Conclusion: Activated fibroblasts can induce the high expression of PD-L1 in the oral and tongue squamous cell carcinoma cell line Cal-27 via the CCL25/CCR9/p-Akt axis, to significantly inhibit the proliferation and IFN-gamma secretion of T cells and promote the immune escape of tongue squamous cell carcinoma cells.


  • Open Access

    SAMHD1 as a prognostic and predictive biomarker in stage II colorectal cancer: A multicenter cohort study

    by Dingyun You, Shuai Zhang, Shan Yan, Yingying Ding, Chunxia Li, Xianshuo Cheng, Lin Wu, Weizhou Wang, Tao Zhang, Zhenhui Li, et al.

    Background: The identification of high-risk population patients is key to the personalized treatment options for the stage II colorectal cancers. The use of proteomics in the prognosis of patients with stage II colorectal cancer remains unclear.Methods: Using quantitative proteomics, we analyzed proteins that are differentially expressed in the tumor and adjacent normal tissues of 11 paired colorectal cancer patients with and without recurrence selected by a nested case-control design. Of the 21 identified proteins, we selected one candidate protein. The association of the corresponding gene of the selected protein with overall survival (OS) and adjuvant chemotherapy was analyzed using two independent cohorts of patients with stages II colorectal cancer.Results: Sterile α motif and histidine-aspartate domain-containing protein 1 (SAMHD1) was selected as the candidate biomarker. A group of 124 patients (12.5%) were stratified into SAMHD1-high subgroup. The 5-year OS rate of SAMHD1-high patients was lower than that of SAMHD1-low patients with stage II colorectal cancer (discovery cohort: hazard ratio [HR] = 2.89, 95% confidence interval [CI], 1.17-7.18, P = 0.016; validation cohort: HR = 2.25, 95% CI, 1.17-4.34, P = 0.013). The Cox multivariate analysis yielded similar results. In a pooled database, the 5-year OS rate was significantly different between patients with and without adjuvant chemotherapy among stage II SAMHD1-low tumors than in patients with stage II SAMHD1-high tumors (88% vs. 77%, P = 0.032).Conclusions: SAMHD1-high expression could help in identifying patients with stage II colorectal cancer with poor prognosis and less benefit from adjuvant chemotherapy.


  • Open Access

    PDGF‑BB regulates the transformation of fibroblasts into cancer‑associated fibroblasts via the lncRNA LURAP1L‑AS1/LURAP1L/IKK/IκB/NF‑κB signaling pathway

    by Xiaobin Ren, Lei Li, Jianhua Wu, Ken Lin, Yongwen He, Li Bian

    The most abundant cells in the tumor microenvironment are cancer‑associated fibroblasts (CAFs). They play an important role in oral squamous cell carcinoma (OSCC) angiogenesis, invasion and metastasis. Platelet‑derived growth factor (PDGF)‑BB has an obvious regulating effect on the formation of CAFs through binding to PDGF receptor (PDGFR)‑β, but the role of long non‑coding (lnc)RNA in PDGF‑BB‑induced transformation of fibroblasts into CAFs remains poorly understood. Using an lncRNA ChIP, 370 lncRNA transcripts were identified to be significantly and differentially expressed between fibroblasts and PDGF‑BB‑induced fibroblasts, including 240 upregulated lncRNAs and 130 downregulated lncRNAs, indicating that lncRNAs are involved in the regulation of the transformation of CAFs. Previous studies have shown that the nuclear factor (NF)‑κB signaling pathway plays an important role in the activation of CAFs. Dual‑luciferase reporter assay and co‑immunoprecipitation were conducted to confirm that the leucine‑rich adaptor protein 1‑like (LURAP1L), which is the target of lncRNA LURAP1L antisense RNA 1 (LURAP1L‑AS1) had a positive regulatory effect on I‑κB kinase (IKK)/NF‑κB signaling. Therefore, LURAP1L‑AS1 was selected and PDGF‑BB was demonstrated to upregulate the expression of LURAP1L‑AS1 and LURAP1L, which was reversed by a PDGFR‑β inhibitor. Subsequently, knocking down LURAP1L‑AS1 suppressed the expression of PDGF‑BB‑induced fibroblast activation marker protein α‑smooth muscle actin, fibroblast activation protein‑α, PDGFR‑β and phosphorylated (p)‑PDGFR‑β. IKKα, p‑IĸB and p‑NF‑κB were downregulated by the knockdown of LURAP1L‑AS1 and upregulated by overexpression of LURAP1L‑AS1. The present study indicates that LURAP1L‑AS1/LURAP1L/IKK/IĸB/NF‑κB plays an important regulatory role in PDGF‑BB‑induced fibroblast activation and may become a potential target for the treatment of OSCC.